SCHEMBL21484772

SCHEMBL21484772

Cc1cc(C(C)(C)C)cc(C)c1C(=O)CBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
GSK3B P49841 2/20 0.39
HTR1D P28221 2/20 0.39
HTR1B P28222 1/20 0.39
POLB P06746 1/20 0.39
RXRB P28702 5/20 0.38
RXRA P19793 4/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
PTPN1 P18031 1/20 0.36
ACHE P22303 1/20 0.36
RXRG P48443 2/20 0.35
ELANE P08246 1/20 0.34
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23364578 0.82 GSK3B (0.52) GSK3BRXRBRXRAMAPTPTPN1
SCHEMBL29059825 0.82 MEN1 (0.45) RAB9AHPGDTSHRHTR1DHTR1B
SCHEMBL1770114 0.81 GSK3B (0.48) RAB9AHPGDGSK3BPOLBALDH1A1
SCHEMBL14992457 0.79 CYP3A4 (0.50) HPGDGSK3BPOLBALDH1A1MAPT
SCHEMBL24090020 0.78 ALDH1A1 (0.41) RAB9AHPGDTSHRHTR1DHTR1B
SCHEMBL1927936 0.78 GSK3B (0.46) RAB9AGSK3BRXRBRXRANPC1
SCHEMBL14992135 0.78 GSK3B (0.41) RAB9ATSHRGSK3BPOLBALDH1A1
SCHEMBL2380078 0.78 GSK3B (0.45) GSK3BPOLBALDH1A1MAPTPTPN1
SCHEMBL5997682 0.77 HTR1D (0.37) RAB9AHPGDTSHRHTR1DHTR1B
SCHEMBL2381417 0.74 GSK3B (0.52) HPGDTSHRGSK3BPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
EP-3556755-B1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES UNIV MASARYKOVA (CZ) 2021-11-17 EP disclosed
EP-3556755-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES Masarykova univerzita (CZ) 2019-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases RNASEH1, DNASE1, FEN1 RAB9A 2879/4885HPGD 4259/4885TSHR 1512/4885
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES RNASEH1, DNASE1, FEN1 RAB9A 2879/4885HPGD 4259/4885TSHR 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.